Compare STMicroelectronics NV (STM) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
STMicroelectronics NV vs TransMedics Group Inc — how do they compare? STMicroelectronics NV trades at $52.06 (market cap $48.14B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: STMicroelectronics NV is far larger — about 17.6× TransMedics Group Inc's market cap, and STMicroelectronics NV pays a 0.68% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold STMicroelectronics NV for 64 Days and TransMedics Group Inc for 24 Days on average.
| STM | TMDX | |
|---|---|---|
Market Cap | $48.14B | $2.74B |
Volume | 9,776,015 | 949,331 |
Sector | Technology | Health |
52-Week High | $79.91 | $150.42 |
52-Week Low | $21.20 | $61.99 |
Typical Hold Time | 64 Days | 24 Days |
Enterprise Value | $45.66B | $3.13B |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
STM (STMicroelectronics) is trading at $52.71, down 6.18% over the past 24 hours amid a broader tech selloff. The stock shows mixed signals with a bearish technical outlook but positive analyst sentiment, including a consensus price target of $77.31. Recent financials reveal declining revenue and negative net income margins, though strong cash flow and a solid balance sheet provide stability. Key developments include growing AI data-center revenue projections and new product launches in automotive sensing.
The outlook for STM hinges on execution in AI and automotive segments, with potential upside from analyst targets. Risks include margin pressure from fab transitions and macroeconomic volatility. Investors should weigh strong institutional support against near-term profitability challenges.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About STMicroelectronics NV
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconductors in France formed STMicroelectronics in 1987. STMicro is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. STMicro is an especially prominent chip supplier into the industrial and automotive industries.
Read more on STM →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
